GSK 1247446A
Alternative Names: GSK1247446ALatest Information Update: 10 Jul 2023
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 20 Nov 2013 No development reported - Phase-II for Influenza virus infections prevention (adults) in France (IM)
- 20 Nov 2013 No development reported - Phase-II for Influenza virus infections prevention (adults) in Germany (IM)
- 20 Nov 2013 No development reported - Phase-II for Influenza virus infections prevention (adults) in Belgium (IM)